HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired Bioenergetics in Clinical Medicine: A Target to Tackle.

Abstract
Mitochondrial energy deficit is considered a key element of different clinical pathologies - from inherited disorders of energy metabolism to drug-induced mitochondrial toxicity, to cardiometabolic and neurodegenerative diseases. However, clinical manifestations of impaired bioenergetics are not easy to recognize, with patient-reported features usually include non-pathognomonic fatigue and weakness, or exercise intolerance, while specific lab tests are missing. Although it is not clear whether poor energetics is a primary deficit or a secondary consequence of specific disorders, improving mitochondrial viability remains a challenging task in both experimental and clinical medicine. In this review, biochemical and clinical evidence of energy deficits were reviewed, along with possible therapeutic options to tackle energy failure and restore bioenergetics.
AuthorsSergej M Ostojic
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 243 Issue 4 Pg. 227-235 (12 2017) ISSN: 1349-3329 [Electronic] Japan
PMID29199262 (Publication Type: Journal Article, Review)
Topics
  • Clinical Medicine
  • Energy Metabolism
  • Humans
  • Inheritance Patterns (genetics)
  • Mitochondrial Diseases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: